Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor

Infection and Immunity

Volumn 66, Issue 6, 1998, Pages 2750-2754

  Maródi, László ^a   Tournay, Christophe ^b   Káposzta, Rita ^a   Johnston Jr , Richard B ^c   Moguilevsky, Nicole ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Brussels University   (Belgium)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MYELOPEROXIDASE;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL KILLING; COLONY FORMATION; FUNGICIDAL ACTIVITY; HOST RESISTANCE; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 2642608658     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.6.2750-2754.1998     Document Type: Article

References (34)

1. Beck-Sague, C. M., and W. R. Jarvis. 1993. National Nosocomial Infections Surveillance System: secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
2. Bentwood, B. J., and P. M. Henson. 1980. The sequential release of granule constituents from human neutrophils. J. Immunol. 124:855-859.
3. Bodey, G. P. 1997. Disseminated candidiasis in neutropenic patients. J. Infect. Dis. 1:S2-S11,
4. deFife, K. M., C. R. Jenney, A. K. McNally, E. Colton, and J. M. Anderson. 1997. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J. Immunol. 158:3385-3390.
5. Fridovich, I. 1978. The biology of oxygen radicals: the Superoxide radical is an agent of oxygen toxicity; Superoxide dismutases provide an important defense. Science 201:875-880.
6. Grisham, M. B., M. M. Jefferson, D. M. Melton, and E. L. Thomas. 1984. Chlorination of endogenous amines by isolated neutrophils: ammonia-dependent bactericidal, cytotoxic, and cytotoxic, activities of the chloramines. J. Biol. Chem. 259:10404-10413.
7. Johnston, R. B., Jr., B. B. Keele, Jr., H. P. Misra, J. E. Lehmeyer, L. S. Webb, R. L. Baehner, and K. V. Rajagopalan. 1975. The role of Superoxide anion generation in phagocytic bactericidal activity: studies with normal and chronic granulomatous disease leukocytes. J. Clin. Invest. 55:1357-1372.
8. Kaplow, L. S. 1965. Simplified myeloperoxidase stain using benzidine dihydrochloride. Blood 26:215-219.
9. Klebanoff, S. J. 1980. Oxygen metabolism and the toxic properties of phagocytes. Ann. Intern. Med. 93:480-489.
10. Krawisz, J. E., P. Sharon, and W. F. Stenson. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344-1350.
11. Lefkowitz, S. S., M. P. Gelderman, D. L. Lefkowitz, N. Moguilevsky, and A. Bollen. 1996. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J. Infect. Dis. 173:1202-1207.
12. Lehrer, R. I. 1969. Antifungal effects of peroxidase systems. J. Bacteriol. 99: 361-378.
13. Levitz, S. M., and R. D. Diamond. 1984. Killing of Aspergillus fumigatus spores and Candida albicans yeast phase by the iron-hydrogen peroxideiodide cytotoxic system: comparison with the myeloperoxidase-hydrogen peroxide-halide system. Infect. Immun. 43:1100-1102.
14. Ludviksson, B. R., O. Thorarensen, T. Gudnason, and S. Halldorsson. 1993. Candida albicans meningitis in a child with myeloperoxidase deficiency. Pediatr. Infect. Dis. J. 12:162-164.
15. 14a.
16. Mahoney, J. A., and S. Gordon. Personal communication.
17. Maródi, L., J. R. Forehand, and R. B. Johnston, Jr. 1991. Mechanisms of host defense against Candida species. II. Biochemical basis for killing of Candida by mononuclear phagocytes. J. Immunol. 146:2790-2794.
18. Maródi, L., H. M. Korchak, and R. B. Johnston, Jr. 1991. Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J. Immunol. 146:2783-2789.
19. Maródi, L., S. Schreiber, D. Anderson, R. P. MacDermott, H. M. Korchak, and R. B. Johnston, Jr. 1993. Enhancement of macrophage candidacidal activity by IFN-γ: increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 91: 2596-2601.
20. Maródi, L., R. Káposzta, D. E. Campbell, R. A. Polin, J. Csongor, and R. B. Johnston, Jr. 1994. Candidacidal mechanisms in the human neonate: impaired IFN-γ activation in newborn infants. J. Immunol. 153:5643-5649.
21. Moguilevsky, N., L. Garcia-Quintana, A. Jacquet, C. Tournay, L. Fabry, R. Pirard, and A. Bollen. 1991. Structural and biological properties of human recombinant myeloperoxidase produced by Chinese hamster ovary cell lines. Eur. J. Biochem. 197:605-614.
22. Nauseef, W. M. 1988. Myeloperoxidase deficiency. Hematol. Oncol. Clin. North Am. 2:135-147.
23. Okuda, T., T. Yasuoka, and N. Oka. 1991. Myeloperoxidase deficiency as a predisposing factor for deep mucocutaneous candidiasis: a case report. J. Oral Maxillofac. Surg. 49:183-186.
24. Pfaller, M. A. 1994. Epidemiology and control of fungal infections. Clin. Infect. Dis. 19:S8-S13.
25. Quian, Q., M. A. Jutila, N. V. Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
26. Segal, A. W., and A. Abo. 1993. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:43-47.
27. Shepherd, V. L., and J. R. Hoidal. 1990. Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am. J. Respir. Cell. Mol. Biol. 2:335-340.
28. Stahl, P. D., J. S. Rodman, M. J. Miller, and P. H. Schlesinger. 1978. Evidence for receptor-mediated binding of glycoproteins, glycoconjugates, and lysosomal glycosidases by macrophages. Proc. Natl. Acad. Sci. USA 75: 1399-1403.
29. Stein, M., S. Keshav, N. Harris, and S. Gordon. 1992. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176:287-292.
30. Thomas, E. L. 1979. Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: nitrogen-chlorine derivatives of bacterial components in bactericidal action against Escherichia coli. Infect. Immun. 23:522-531.
31. Tournay, C., P. J. Courtoy, L. Maródi, P. Totté, J. Werenne, A. Jacquet, L. Garcia-Quintana, A. Bollen, and N. Moguilevsky. 1996. Uptake of recombinant myeloperoxidase, free or fused to Fcγ, by macrophages enhances killing activity toward microorganisms. DNA Cell Biol. 15:617-624.
32. Wang, M., H. Friedman, and J. Y. Djeu. 1989. Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage CSF, and macrophage CSF. J. Immunol. 143:671-677.
33. Weber, M. I., A. Abela, L. Repintigny, L. Garel, and N. Lapointe. 1987. Myeloperoxidase deficiency with extensive Candidal osteomyelitis of the base of the skull. Pediatrics 80:876-879.
34. Weiss, S. J., R. Klein, A. Slivka, and M. Wei. 1982. Chlorination of taurine by human neutrophils: evidence for hypochlorous acid generation. J. Clin. Invest. 70:598-607.